NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $84,072 | -13.3% | 37,200 | +22.8% | 0.01% | -40.0% |
| Q3 2022 | $97,000 | -68.9% | 30,300 | -63.1% | 0.02% | -65.5% |
| Q2 2022 | $312,000 | +13.5% | 82,200 | +497.0% | 0.06% | -7.9% |
| Q1 2021 | $275,000 | -8.3% | 13,769 | -21.9% | 0.06% | -19.2% |
| Q4 2020 | $300,000 | -52.8% | 17,630 | +35.5% | 0.08% | -45.5% |
| Q2 2018 | $635,000 | -19.9% | 13,009 | +74.3% | 0.14% | -29.2% |
| Q1 2018 | $793,000 | -13.8% | 7,465 | -51.5% | 0.20% | +7.4% |
| Q4 2017 | $920,000 | +251.1% | 15,400 | +37.9% | 0.19% | +51.6% |
| Q1 2017 | $262,000 | -11.8% | 11,170 | -53.8% | 0.12% | +67.6% |
| Q4 2016 | $297,000 | – | 24,200 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |